Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Masayuki Miuchi"'
Autor:
Takafumi Akagami, Jun-ichiro Miyagawa, Tomoyuki Katsuno, Yoshiki Kusunoki, Masaru Tokuda, Mitsuyoshi Namba, Masayuki Miuchi, Akira Kushida, Takashi Ikawa, Takashi Inagaki, Toshihiro Matsuo
Publikováno v:
Journal of Diabetes Investigation
Aims/introduction The aims of the present study were to investigate the performance of a novel sandwich enzyme‐linked immunosorbent assay (ELISA) for measuring glucagon (1–29) with monoclonal antibodies against both the C‐ and N‐terminal regi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c3ad791ec027a371cccbce656acf5e3
https://doi.org/10.1111/jdi.12400
https://doi.org/10.1111/jdi.12400
Autor:
Jun-ichiro Miyagawa, Fumihiro Ochi, Takafumi Akagami, Mitsuyoshi Namba, Rie Nakae, Tomoyuki Katsuno, Masayuki Miuchi, Masaru Tokuda, Kahori Watanabe, Yoshiki Kusunoki
Publikováno v:
Gynecological Endocrinology. 31:929-933
The aim of this study in patients with gestational diabetes mellitus (GDM) was to evaluate the relationship of insulin resistance and secretion to area-under-the-sensor glucose concentration-time curve from before to 120 min postmeal (CGM-AUC(0-120 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e49893440eeb48defcf0d40da93c61e
https://doi.org/10.3109/09513590.2015.1075498
https://doi.org/10.3109/09513590.2015.1075498
Autor:
Mitsuyoshi Namba, Masayuki Miuchi, Yoshiki Kusunoki, Tomoyuki Katsuno, Kazuki Murai, Toshihiro Matsuo, Jun-ichiro Miyagawa, Fumihiro Ochi, Masaru Tokuda
Publikováno v:
Drugs in R&D
Background Sitagliptin inhibits dipeptidyl peptidase-4, which inactivates the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide. To assess its antidiabetic potency, we used meal tolerance tests (MTTs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f20c37a0b5707400a95f49a715362ac2
http://europepmc.org/articles/PMC4311653
http://europepmc.org/articles/PMC4311653
Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes
Autor:
Mitsuyoshi Namba, Yoshiki Kusunoki, Tomoyuki Katsuno, Masayuki Miuchi, Kazuki Murai, Kana Miyakoshi, Masaru Tokuda, Fumihiro Ochi, Tomoya Hamaguchi, Jun-ichiro Miyagawa
Publikováno v:
Endocrine Journal. 61:365-372
The effects of exenatide on glycemic control, lipid metabolism, blood pressure, and gastrointestinal symptoms were investigated in obese Japanese patients with type 2 diabetes mellitus. Twenty-six outpatients were enrolled and administered 5 μg of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e040890b81a470beb9c3fafe955bc342
https://doi.org/10.1507/endocrj.ej14-0009
https://doi.org/10.1507/endocrj.ej14-0009
Autor:
Kana Miyakoshi, Masaru Tokuda, Yoshiki Kusunoki, Jun-ichiro Miyagawa, Rie Nakae, Tomoyuki Katsuno, Takafumi Akagami, Fumihiro Ochi, Kazuki Murai, Masayuki Miuchi, Mitsuyoshi Namba, Takashi Ikawa, Tomoya Hamaguchi
Publikováno v:
Diabetes Therapy
Introduction Insulin degludec is a new, ultra-long-acting basal insulin. The aim of this study was to analyze the changes of basal insulin dose and blood glucose profile in basal–bolus therapy of type 1 diabetes mellitus (T1DM) at the switching of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7195a2e657bf7607dc4dfb787fe741e
http://europepmc.org/articles/PMC3889322
http://europepmc.org/articles/PMC3889322
Autor:
Hiroyuki Konya, Mai Kamitani, Jun-ichiro Miyagawa, Taku Tsunoda, Mitsuyoshi Namba, Tomoyuki Katsuno, Tomoya Hamaguchi, Yuzo Yano, Masayuki Miuchi
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Patients with diabetes mellitus are at increased risk from cardiovascular-related morbidity and mortality as compared with healthy individuals. An association between the postprandial metabolic state and atherogenesis has been observed in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bba18d6c100d966ca5b88fde1884c5f6
http://europepmc.org/articles/PMC3769413
http://europepmc.org/articles/PMC3769413
Autor:
Mitsuyoshi Namba, Masaru Tokuda, Etsuko Nagai, Yoshiki Kusunoki, Tomoyuki Katsuno, Kosuke Konishi, Kazuki Murai, Toshihiro Matsuo, Humihiro Ochi, Masayuki Miuchi, Yutaka Harano, Tomoya Hamaguchi, Aya Maeda, Jun-ichiro Miyagawa
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction Incretins might play some pathophysiological role in glucose metabolism in diabetes and obesity; it is not clear whether or not the amount and the pattern of incretin secretion vary with different types of sugars. To evaluate the ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be74ae0bb9c5aa63c445cd6a162eea27
https://doi.org/10.1111/jdi.12045
https://doi.org/10.1111/jdi.12045
Autor:
Fumihiro Ochi, Makiko Myojin, Kana Miyakoshi, Masaru Tokuda, Kazuki Murai, Tomoya Hamaguchi, Toshihiro Matsuo, Takashi Ikawa, Mitsuyoshi Namba, Jun-ichiro Miyagawa, Tomoyuki Katsuno, Yoshiki Kusunoki, Masayuki Miuchi
Publikováno v:
Endocrine Journal. 60:431-439
Acarbose was administered at 300 mg/day to patients with type 2 diabetes mellitus (T2DM) who had been taking 25 mg/day of alogliptin, and levels of blood glucose were analyzed by continuous glucose monitoring (CGM) for 3 days. The mean blood glucose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6350365d9e82308ad1327f6d69e0f653
https://doi.org/10.1507/endocrj.ej12-0290
https://doi.org/10.1507/endocrj.ej12-0290
Autor:
Masayuki Miuchi, Yoshiki Kusunoki, Jun-ichiro Miyagawa, Tomoya Hamaguchi, C Inokuchi, Mitsuyoshi Namba, Etsuko Nagai, Y Nakamura, Kosuke Konishi, Tetsuya Ishikawa, Hiroyuki Konya, Tomoyuki Katsuno, T Ueyama, Y Kimura
Publikováno v:
Journal of International Medical Research. 37:1904-1912
This study investigated the effects of mitiglinide in 16 patients with type 2 diabetes mellitus treated with 30 mg/day mitiglinide, divided into three doses given just before each meal, for approximately 12 months. A 450 kcal meal tolerance test was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65f2c3412f0e4803dbca27927dad17ba
https://doi.org/10.1177/147323000903700628
https://doi.org/10.1177/147323000903700628
Publikováno v:
Nihon Naika Gakkai Zasshi. 98:809-816
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e5db3c9c5d04b942f8d53d7d648935a
https://doi.org/10.2169/naika.98.809
https://doi.org/10.2169/naika.98.809